Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glyceryl trinitrate versus topical diltiazem for chronic anal fissure
PACTR202507821064255Phase 3Unknown
- Sponsor
- Al-Azhar University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nitroglycerin and diltiazem in chronic anal fissure (CAF) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Treatment rates in both groups. Status: unknown.
02
Drugs
nitroglycerindiltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on PACTR202507821064255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507821064255.